CYTOMEGALOVIRUS INFECTION
Clinical trials for CYTOMEGALOVIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRUS INFECTION trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer drug wake up immune cells to beat HIV-Related infections?
Disease control Not yet recruitingThis study tests a drug called Sintilimab, which is normally used for cancer, to see if it can help people with HIV who have infections that won't go away with standard treatment. The drug works by 'waking up' exhausted immune cells. Fifty adults with HIV and a hard-to-treat infe…
Matched conditions: CYTOMEGALOVIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Blood test after transplant may flag hidden virus risk
Knowledge-focused Not yet recruitingThis study follows 123 stem cell transplant patients to see if measuring their immune response to CMV after stopping a preventive drug (letermovir) can predict late infections. Participants will have regular blood tests up to 200 days after transplant. The goal is to learn whethe…
Matched conditions: CYTOMEGALOVIRUS INFECTION
Sponsor: Maimónides Biomedical Research Institute of Córdoba • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC